Clinical trial
Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With…
NCT00353938 · Lykos Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00353938 |
|---|---|
| Title | Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder |
| Official title | Phase II Pilot Randomized Double-Blind Placebo-Controlled Study of 3,4-methylenedioxymethamphetamine (MDMA)Assisted Psychotherapy in Posttraumatic Stress Disorder (PTSD)- Switzerland |
| Lead sponsor | Lykos Therapeutics, Industry |
| Collaborators | Swiss Medical Society for Psycholytic Therapy |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Posttraumatic Stress Disorder |
| Intervention type | Behavioral, Drug |
| Interventions | 3, 4-methylenedioxymethamphetamine (125 mg), 4-methyelendioxymethamphetamine (25 mg), Therapy |
| Enrollment | 14 |
| Start date | Sep 13, 2006 |
| Primary completion | Sep 2, 2009 |
| Completion | Jan 10, 2011 |
| First posted | Jul 19, 2006 |
| Last update posted | Jul 15, 2024 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: